LFA
GILD icon

Legacy Financial Advisors’s Gilead Sciences GILD Stock Holding History

Legacy Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$679K Sell
5,376
-118
-2% -$15.5K 0.08% 187
2026
Q1 		$766K Buy
5,494
+649
+13% +$90.9K 0.11% 166
2025
Q4 		$595K Sell
4,845
-10
-0.2% -$1.22K 0.08% 199
2025
Q3 		$539K Buy
4,855
+434
+10% +$49.3K 0.07% 223
2025
Q2 		$490K Buy
4,421
+758
+21% +$80.7K 0.08% 205
2025
Q1 		$410K Buy
3,663
+465
+15% +$48K 0.07% 230
2024
Q4 		$295K Buy
+3,198
New +$288K 0.05% 273
2024
Q2 		– Sell
-4,211
Closed -$308K – 344
2024
Q1 		$308K Sell
4,211
-6,118
-59% -$470K 0.06% 244
2023
Q4 		$837K Buy
10,329
+684
+7% +$53.2K 0.16% 99
2023
Q3 		$723K Buy
9,645
+18
+0.2% +$1.38K 0.14% 95
2023
Q2 		$742K Hold
9,627
– – 0.14% 89
2023
Q1 		$799K Sell
9,627
-920
-9% -$76.2K 0.16% 73
2022
Q4 		$905K Buy
10,547
+1,651
+19% +$131K 0.2% 65
2022
Q3 		$549K Buy
8,896
+251
+3% +$15.8K 0.13% 89
2022
Q2 		$534K Buy
8,645
+1,118
+15% +$69.2K 0.13% 84
2022
Q1 		$447K Sell
7,527
-994
-12% -$63.5K 0.1% 113
2021
Q4 		$619K Buy
8,521
+485
+6% +$33.4K 0.14% 69
2021
Q3 		$561K Buy
8,036
+591
+8% +$41.5K 0.14% 68
2021
Q2 		$513K Buy
7,445
+661
+10% +$44.1K 0.13% 70
2021
Q1 		$438K Buy
6,784
+803
+13% +$51.8K 0.12% 73
2020
Q4 		$348K Buy
5,981
+381
+7% +$23K 0.1% 85
2020
Q3 		$354K Buy
+5,600
New +$388K 0.11% 72
2019
Q2 		– Sell
-324
Closed -$21K – 418
2019
Q1 		$21K Sell
324
-165
-34% -$11K 0.01% 443
2018
Q4 		$31K Buy
489
+383
+361% +$26.8K 0.01% 329
2018
Q3 		$8K Buy
106
+75
+242% +$5.66K ﹤0.01% 581
2018
Q2 		$2K Sell
31
-155
-83% -$10.9K ﹤0.01% 819
2018
Q1 		$13K Buy
186
+5
+3% +$397 0.01% 425
2017
Q4 		$12K Buy
+181
New +$13.7K ﹤0.01% 438

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Legacy Financial Advisors's GILD Position: Q2 2026 in Review

Legacy Financial Advisors reduced its Gilead Sciences (GILD) stake by 2.1% in Q2 2026, selling an estimated $15.5K and leaving 5,376 shares worth $679K. The position accounts for 0.08% of the portfolio, ranked #187.

Legacy Financial Advisors first reported a position in GILD in Q4 2017 and has held it in 28 quarters since. The position peaked at $905K in Q4 2022. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Legacy Financial Advisors held 5,376 shares of Gilead Sciences worth $679K as of Q2 2026.
  • Legacy Financial Advisors sold 118 Gilead Sciences shares in Q2 2026, an estimated $15.5K.
  • Gilead Sciences made up 0.08% of Legacy Financial Advisors's portfolio in Q2 2026, its #187 holding.
  • Legacy Financial Advisors first reported a position in Gilead Sciences in Q4 2017 and has held it in 28 quarters since.
  • Legacy Financial Advisors's Gilead Sciences position peaked at $905K in Q4 2022.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Legacy Financial Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.